⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
UCB News
United Community Banks, Inc.
Refractory Epilepsy Treatment: Transforming Healthcare with Personalized Therapy
globenewswire.com
UCB
LIVN
Lee's Pharmaceutical Holdings Limited Acquires Staccato® One Breath Technology® Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights
prnewswire.com
UCB
United Community Banks, Inc. Announces Extension of Share Repurchase Program
globenewswire.com
UCB
Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
AMGN
PFE
LLY
AZN
BMY
NVS
SNY
GSK
UCB
ARQT
REGN
INCY
ABBV
BIIB
MRK
JNJ
VNDA
RAPT
CHAI
ONON
ION
ASMB
CRVS
APG
KSCP
KYMR
XBI
IBB
ADSK
CDNS
SNPS
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduced countable motor seizure frequency in CDKL5 deficiency disorder
prnewswire.com
UCB
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder USA - English USA - English
prnewswire.com
UCB
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder USA - English USA - English
prnewswire.com
UCB
UCB shares leading scientific research and advances at American Epilepsy Society Annual Meeting
prnewswire.com
UCB
Citizen Health Joins Forces with UCB to Accelerate Drug Development across Epilepsy and Rare Diseases
globenewswire.com
UCB
Mitochondrial Myopathies Market to Register Stunning Growth at a CAGR of 26.5% During the Forecast Period (2025-2034) Driven by Recent Approvals and Pipeline Advancements and Rising Awareness | DelveInsight
prnewswire.com
BCLI
PTC
SBTX
UCB